Commercially Available Insulin Products Demonstrate Consistency With Product Labeling Throughout All Seasons in the U.S
Diabetes Care
.
2022 Nov 1;45(11):e166-e168.
doi: 10.2337/dc22-0972.
Authors
Timothy J Garrett
1
,
Sina Feizbakhsh Bazargani
2
,
Taylor Harmon
2
,
Jordan Kruse
1
,
Philip Atkinson
3
,
Eoin P Quinlivan
1
,
Lynn Ang
4
,
Irl B Hirsch
5
,
Lori Laffel
6
,
Massimo Pietropaolo
7
,
Michael J Haller
8
,
Mark A Atkinson
1
3
8
Affiliations
1
Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.
2
Department of Chemistry, College of Liberal Arts and Sciences, University of Florida, Gainesville, FL.
3
Insulin for Life USA, Gainesville, FL.
4
Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
5
Endocrine and Diabetes Care Center, University of Washington Medical Center-Roosevelt, Seattle, WA.
6
Joslin Diabetes Center, Harvard Medical School, Boston, MA.
7
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX.
8
Department of Pediatrics, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
PMID:
36102751
DOI:
10.2337/dc22-0972
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Insulin*
Product Labeling*
Seasons
Substances
Insulin